Myopathy with SQSTM1 and TIA1 variants: Clinical and pathological features

Zhiyv Niu, Carly Sabine Pontifex, Sarah Berini, Leslie E. Hamilton, Elie Naddaf, Eric D Wieben, Ross A. Aleff, Kristina Martens, Angela Gruber, Andrew G Engel, Gerald Pfeffer, Margherita Milone

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: The aim of this study is to identify the molecular defect of three unrelated individuals with late-onset predominant distal myopathy; to describe the spectrum of phenotype resulting from the contributing role of two variants in genes located on two different chromosomes; and to highlight the underappreciated complex forms of genetic myopathies. Patients and methods: Clinical and laboratory data of three unrelated probands with predominantly distal weakness manifesting in the sixth-seventh decade of life, and available affected and unaffected family members were reviewed. Next-generation sequencing panel, whole exome sequencing, and targeted analyses of family members were performed to elucidate the genetic etiology of the myopathy. Results: Genetic analyses detected two contributing variants located on different chromosomes in three unrelated probands: a heterozygous pathogenic mutation in SQSTM1 (c.1175C>T, p. Pro392Leu) and a heterozygous variant in TIA1 (c.1070A>G, p. Asn357Ser). The affected fraternal twin of one proband also carries both variants, while the unaffected family members harbor one or none. Two unrelated probands (family 1, II.3, and family 3, II.1) have a distal myopathy with rimmed vacuoles that manifested with index extensor weakness; the other proband (family 2, I.1) has myofibrillar myopathy manifesting with hypercapnic respiratory insufficiency and distal weakness. Conclusion: The findings indicate that all the affected individuals have a myopathy associated with both variants in SQSTM1 and TIA1, respectively, suggesting that the two variants determine the phenotype and likely functionally interact. We speculate that the TIA1 variant is a modifier of the SQSTM1 mutation. We identify the combination of SQSTM1 and TIA1 variants as a novel genetic defect associated with myofibrillar myopathy and suggest to consider sequencing both genes in the molecular investigation of myopathy with rimmed vacuoles and myofibrillar myopathy although additional studies are needed to investigate the digenic nature of the disease.

Original languageEnglish (US)
Article number147
JournalFrontiers in Neurology
Volume9
Issue numberMAR
DOIs
StatePublished - Mar 19 2018

Fingerprint

Muscular Diseases
Distal Myopathies
Chromosomes
Exome
Phenotype
Dizygotic Twins
Mutation
Respiratory Insufficiency
Genes
Myofibrillar Myopathy

Keywords

  • Distal myopathy
  • Myofibrillar myopathy
  • Respiratory insufficiency
  • Rimmed vacuoles
  • SQSTM
  • TIA

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Myopathy with SQSTM1 and TIA1 variants : Clinical and pathological features. / Niu, Zhiyv; Pontifex, Carly Sabine; Berini, Sarah; Hamilton, Leslie E.; Naddaf, Elie; Wieben, Eric D; Aleff, Ross A.; Martens, Kristina; Gruber, Angela; Engel, Andrew G; Pfeffer, Gerald; Milone, Margherita.

In: Frontiers in Neurology, Vol. 9, No. MAR, 147, 19.03.2018.

Research output: Contribution to journalArticle

Niu, Z, Pontifex, CS, Berini, S, Hamilton, LE, Naddaf, E, Wieben, ED, Aleff, RA, Martens, K, Gruber, A, Engel, AG, Pfeffer, G & Milone, M 2018, 'Myopathy with SQSTM1 and TIA1 variants: Clinical and pathological features', Frontiers in Neurology, vol. 9, no. MAR, 147. https://doi.org/10.3389/fneur.2018.00147
Niu, Zhiyv ; Pontifex, Carly Sabine ; Berini, Sarah ; Hamilton, Leslie E. ; Naddaf, Elie ; Wieben, Eric D ; Aleff, Ross A. ; Martens, Kristina ; Gruber, Angela ; Engel, Andrew G ; Pfeffer, Gerald ; Milone, Margherita. / Myopathy with SQSTM1 and TIA1 variants : Clinical and pathological features. In: Frontiers in Neurology. 2018 ; Vol. 9, No. MAR.
@article{e513dd89780a4ecd89935a1b890b11d2,
title = "Myopathy with SQSTM1 and TIA1 variants: Clinical and pathological features",
abstract = "Objective: The aim of this study is to identify the molecular defect of three unrelated individuals with late-onset predominant distal myopathy; to describe the spectrum of phenotype resulting from the contributing role of two variants in genes located on two different chromosomes; and to highlight the underappreciated complex forms of genetic myopathies. Patients and methods: Clinical and laboratory data of three unrelated probands with predominantly distal weakness manifesting in the sixth-seventh decade of life, and available affected and unaffected family members were reviewed. Next-generation sequencing panel, whole exome sequencing, and targeted analyses of family members were performed to elucidate the genetic etiology of the myopathy. Results: Genetic analyses detected two contributing variants located on different chromosomes in three unrelated probands: a heterozygous pathogenic mutation in SQSTM1 (c.1175C>T, p. Pro392Leu) and a heterozygous variant in TIA1 (c.1070A>G, p. Asn357Ser). The affected fraternal twin of one proband also carries both variants, while the unaffected family members harbor one or none. Two unrelated probands (family 1, II.3, and family 3, II.1) have a distal myopathy with rimmed vacuoles that manifested with index extensor weakness; the other proband (family 2, I.1) has myofibrillar myopathy manifesting with hypercapnic respiratory insufficiency and distal weakness. Conclusion: The findings indicate that all the affected individuals have a myopathy associated with both variants in SQSTM1 and TIA1, respectively, suggesting that the two variants determine the phenotype and likely functionally interact. We speculate that the TIA1 variant is a modifier of the SQSTM1 mutation. We identify the combination of SQSTM1 and TIA1 variants as a novel genetic defect associated with myofibrillar myopathy and suggest to consider sequencing both genes in the molecular investigation of myopathy with rimmed vacuoles and myofibrillar myopathy although additional studies are needed to investigate the digenic nature of the disease.",
keywords = "Distal myopathy, Myofibrillar myopathy, Respiratory insufficiency, Rimmed vacuoles, SQSTM, TIA",
author = "Zhiyv Niu and Pontifex, {Carly Sabine} and Sarah Berini and Hamilton, {Leslie E.} and Elie Naddaf and Wieben, {Eric D} and Aleff, {Ross A.} and Kristina Martens and Angela Gruber and Engel, {Andrew G} and Gerald Pfeffer and Margherita Milone",
year = "2018",
month = "3",
day = "19",
doi = "10.3389/fneur.2018.00147",
language = "English (US)",
volume = "9",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",
number = "MAR",

}

TY - JOUR

T1 - Myopathy with SQSTM1 and TIA1 variants

T2 - Clinical and pathological features

AU - Niu, Zhiyv

AU - Pontifex, Carly Sabine

AU - Berini, Sarah

AU - Hamilton, Leslie E.

AU - Naddaf, Elie

AU - Wieben, Eric D

AU - Aleff, Ross A.

AU - Martens, Kristina

AU - Gruber, Angela

AU - Engel, Andrew G

AU - Pfeffer, Gerald

AU - Milone, Margherita

PY - 2018/3/19

Y1 - 2018/3/19

N2 - Objective: The aim of this study is to identify the molecular defect of three unrelated individuals with late-onset predominant distal myopathy; to describe the spectrum of phenotype resulting from the contributing role of two variants in genes located on two different chromosomes; and to highlight the underappreciated complex forms of genetic myopathies. Patients and methods: Clinical and laboratory data of three unrelated probands with predominantly distal weakness manifesting in the sixth-seventh decade of life, and available affected and unaffected family members were reviewed. Next-generation sequencing panel, whole exome sequencing, and targeted analyses of family members were performed to elucidate the genetic etiology of the myopathy. Results: Genetic analyses detected two contributing variants located on different chromosomes in three unrelated probands: a heterozygous pathogenic mutation in SQSTM1 (c.1175C>T, p. Pro392Leu) and a heterozygous variant in TIA1 (c.1070A>G, p. Asn357Ser). The affected fraternal twin of one proband also carries both variants, while the unaffected family members harbor one or none. Two unrelated probands (family 1, II.3, and family 3, II.1) have a distal myopathy with rimmed vacuoles that manifested with index extensor weakness; the other proband (family 2, I.1) has myofibrillar myopathy manifesting with hypercapnic respiratory insufficiency and distal weakness. Conclusion: The findings indicate that all the affected individuals have a myopathy associated with both variants in SQSTM1 and TIA1, respectively, suggesting that the two variants determine the phenotype and likely functionally interact. We speculate that the TIA1 variant is a modifier of the SQSTM1 mutation. We identify the combination of SQSTM1 and TIA1 variants as a novel genetic defect associated with myofibrillar myopathy and suggest to consider sequencing both genes in the molecular investigation of myopathy with rimmed vacuoles and myofibrillar myopathy although additional studies are needed to investigate the digenic nature of the disease.

AB - Objective: The aim of this study is to identify the molecular defect of three unrelated individuals with late-onset predominant distal myopathy; to describe the spectrum of phenotype resulting from the contributing role of two variants in genes located on two different chromosomes; and to highlight the underappreciated complex forms of genetic myopathies. Patients and methods: Clinical and laboratory data of three unrelated probands with predominantly distal weakness manifesting in the sixth-seventh decade of life, and available affected and unaffected family members were reviewed. Next-generation sequencing panel, whole exome sequencing, and targeted analyses of family members were performed to elucidate the genetic etiology of the myopathy. Results: Genetic analyses detected two contributing variants located on different chromosomes in three unrelated probands: a heterozygous pathogenic mutation in SQSTM1 (c.1175C>T, p. Pro392Leu) and a heterozygous variant in TIA1 (c.1070A>G, p. Asn357Ser). The affected fraternal twin of one proband also carries both variants, while the unaffected family members harbor one or none. Two unrelated probands (family 1, II.3, and family 3, II.1) have a distal myopathy with rimmed vacuoles that manifested with index extensor weakness; the other proband (family 2, I.1) has myofibrillar myopathy manifesting with hypercapnic respiratory insufficiency and distal weakness. Conclusion: The findings indicate that all the affected individuals have a myopathy associated with both variants in SQSTM1 and TIA1, respectively, suggesting that the two variants determine the phenotype and likely functionally interact. We speculate that the TIA1 variant is a modifier of the SQSTM1 mutation. We identify the combination of SQSTM1 and TIA1 variants as a novel genetic defect associated with myofibrillar myopathy and suggest to consider sequencing both genes in the molecular investigation of myopathy with rimmed vacuoles and myofibrillar myopathy although additional studies are needed to investigate the digenic nature of the disease.

KW - Distal myopathy

KW - Myofibrillar myopathy

KW - Respiratory insufficiency

KW - Rimmed vacuoles

KW - SQSTM

KW - TIA

UR - http://www.scopus.com/inward/record.url?scp=85044111551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044111551&partnerID=8YFLogxK

U2 - 10.3389/fneur.2018.00147

DO - 10.3389/fneur.2018.00147

M3 - Article

AN - SCOPUS:85044111551

VL - 9

JO - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

IS - MAR

M1 - 147

ER -